Progenics Pharmaceuticals, Inc. (PGNX) Reaches $5.18 After 6.00% Up Move; Vornado Realty Trust (VNO) SI Increased By 7.31%

August 10, 2017 - By Ellis Scott

Vornado Realty Trust (NYSE:VNO) had an increase of 7.31% in short interest. VNO’s SI was 2.72 million shares in August as released by FINRA. Its up 7.31% from 2.53 million shares previously. With 939,600 avg volume, 3 days are for Vornado Realty Trust (NYSE:VNO)’s short sellers to cover VNO’s short positions. The SI to Vornado Realty Trust’s float is 1.55%. About 69,102 shares traded. Vornado Realty Trust (NYSE:VNO) has risen 1.51% since August 10, 2016 and is uptrending. It has underperformed by 15.19% the S&P500.

The stock of Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) is a huge mover today! About 309,876 shares traded. Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) has risen 48.41% since August 10, 2016 and is uptrending. It has outperformed by 31.71% the S&P500.The move comes after 8 months positive chart setup for the $363.77 million company. It was reported on Aug, 10 by Barchart.com. We have $5.49 PT which if reached, will make NASDAQ:PGNX worth $21.83 million more.

Since February 21, 2017, it had 0 buys, and 1 insider sale for $232,187 activity. Shares for $232,187 were sold by Iocco Matthew on Tuesday, February 21.

Investors sentiment decreased to 0.93 in Q4 2016. Its down 0.13, from 1.06 in 2016Q3. It dived, as 47 investors sold Vornado Realty Trust shares while 141 reduced holdings. 45 funds opened positions while 130 raised stakes. 163.94 million shares or 0.88% more from 162.52 million shares in 2016Q3 were reported. Private Grp Inc stated it has 18,763 shares or 0.11% of all its holdings. Adage Prtn Grp Incorporated Limited Com has 245,359 shares. Price T Rowe Associate Incorporated Md stated it has 0.07% in Vornado Realty Trust (NYSE:VNO). Shell Asset Commerce accumulated 11,202 shares. Envestnet Asset Mgmt Incorporated reported 28,226 shares. Janney Montgomery Scott Limited Liability invested in 0% or 2,053 shares. Dnb Asset Mgmt As accumulated 0% or 12,828 shares. Kemper Corp Master Retirement Tru accumulated 10,100 shares. Thrivent Fincl For Lutherans reported 96,648 shares or 0.04% of all its holdings. Farmers Merchants Invs holds 15 shares. Research & Mgmt holds 0.02% or 626 shares. Canada Pension Plan Investment Board holds 0.11% or 281,999 shares. Pensionfund Dsm Netherlands holds 0.42% in Vornado Realty Trust (NYSE:VNO) or 27,765 shares. Nomura Asset Management Co Ltd owns 141,560 shares or 0.27% of their US portfolio. 6,891 were reported by Exane Derivatives.

Among 7 analysts covering Vornado Realty Trust (NYSE:VNO), 4 have Buy rating, 0 Sell and 3 Hold. Therefore 57% are positive. Vornado Realty Trust had 20 analyst reports since August 5, 2015 according to SRatingsIntel. As per Tuesday, January 26, the company rating was downgraded by Barclays Capital. The firm earned “Hold” rating on Monday, May 16 by Deutsche Bank. SunTrust maintained Vornado Realty Trust (NYSE:VNO) on Thursday, September 3 with “Neutral” rating. The firm earned “Buy” rating on Wednesday, July 19 by Citigroup. The stock of Vornado Realty Trust (NYSE:VNO) has “Outperform” rating given on Tuesday, April 12 by Credit Suisse. The firm has “Hold” rating by Evercore given on Monday, March 21. The firm earned “Hold” rating on Monday, March 21 by Deutsche Bank. The firm has “Equal-Weight” rating given on Tuesday, July 18 by Barclays Capital. Barclays Capital maintained Vornado Realty Trust (NYSE:VNO) on Friday, September 4 with “Overweight” rating. The company was maintained on Tuesday, July 19 by Barclays Capital.

Vornado Realty Trust is a real estate investment trust . The company has market cap of $14.65 billion. The Firm conducts its business through Vornado Realty L.P. (the Operating Partnership). It has a 16.83 P/E ratio. The Firm operates through two divisions: New York and Washington, DC.

Progenics Pharmaceuticals, Inc. is engaged in developing medicines and other products for targeting and treating cancer. The company has market cap of $363.77 million. The Company’s pipeline includes therapeutic agents designed to target cancer ; prostate specific membrane antigen (PSMA)-targeted imaging agents for prostate cancer (1404 and PyL), and imaging analysis tools. It currently has negative earnings. It also includes commercial product, RELISTOR (methylnaltrexone bromide) for opioid-induced constipation.

Among 5 analysts covering Progenics Pharm (NASDAQ:PGNX), 5 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Progenics Pharm had 10 analyst reports since August 6, 2015 according to SRatingsIntel. The firm earned “Strong Buy” rating on Monday, February 6 by Needham. The rating was maintained by Brean Capital on Thursday, August 6 with “Buy”. On Wednesday, August 9 the stock rating was maintained by Cantor Fitzgerald with “Buy”. The rating was downgraded by Zacks to “Buy” on Friday, August 7. The firm has “Buy” rating given on Friday, August 7 by Needham. The firm earned “Buy” rating on Thursday, June 8 by Jefferies. Aegis Capital initiated the shares of PGNX in report on Thursday, October 27 with “Buy” rating. The firm earned “Buy” rating on Tuesday, June 20 by Needham. Jefferies upgraded Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) on Friday, October 23 to “Buy” rating.

Investors sentiment increased to 1.22 in 2016 Q4. Its up 0.05, from 1.17 in 2016Q3. It improved, as 12 investors sold Progenics Pharmaceuticals, Inc. shares while 38 reduced holdings. 31 funds opened positions while 30 raised stakes. 59.59 million shares or 0.65% more from 59.20 million shares in 2016Q3 were reported. California Pub Employees Retirement System reported 0% stake. Oxford Asset owns 275,415 shares. Ellington Mngmt Grp Limited Company has 13,000 shares. Northern Trust Corporation accumulated 0% or 822,911 shares. 4,027 were reported by Royal Bank Of Canada. Baker Bros Advisors Lp stated it has 0.27% in Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX). The Colorado-based Alps Advsrs has invested 0% in Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX). Fifth Third Financial Bank holds 0% or 5,000 shares. California State Teachers Retirement owns 143,511 shares or 0% of their US portfolio. Mufg Americas Corp accumulated 213 shares or 0% of the stock. Moreover, Envestnet Asset Management has 0% invested in Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) for 3,742 shares. Cornerstone Cap Mngmt Ltd invested in 33,500 shares or 0% of the stock. Reilly Fincl Advsrs Ltd Llc invested in 1,300 shares or 0% of the stock. Paloma Prtnrs Company invested 0% in Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX). Geode Capital Mngmt Ltd Liability Corporation has 590,726 shares for 0% of their portfolio.

Since February 13, 2017, it had 0 buys, and 1 sale for $5.82 million activity. Broadfin Healthcare Master Fund Ltd sold $5.82M worth of stock or 602,600 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Twitter Auto Publish Powered By : XYZScripts.com